Cholesterol

Statin Cost Efficacy

The Statin Cost Efficacy Grid details the cost and LDL lowering efficacy of all currently available statins. Statins and doses are highlighted based on evidence or cost efficacy. The green column highlights the minimum therapeutic bar for treatment of low and moderate risk patients. The orange column highlights the minimum therapeutic bar to halt atherosclerotic progression. The pink column highlights the minimum therapeutic bar for treatment of high risk patients or patients with atherosclerotic risk equivalents. The bright orange column highlights the minimum therapeutic bar to induce atherosclerotic regression. See the Lipid Optimization Tool for the therapeutic protocol.

[1] Ann Intern Med. 1996;125:990-1000.
[2]Am J Card;1998:82:311-316.
[3]Arterioscler Thromb Vasc Biol. 1995;15:678-682.
[4]Am J Card 1998;81: 582-587
[5] Am J Cardiol 2003;91:33–41
[6]EHJ 2002, 4, (August) Abstract Supplement: Abs 212, page 19.
[7]BMJ 326 974040:1423.
[8]JACC 2003 (suppl):315A-316A. Abs 876-2.

This chart is available for download as a PDF in the Downloads section.

Return to Top

CV Toolbox One | Cholesterol
Lipid Lowering Evidence | Landmark Trials | Cholesterol Feedback | Primary Prevention | Diet for Hyperlipidemia
Lipid Optimization Tool | Statin Cost Efficacy | Lipid Targets/Care Gap | Statin Advisory | Statin Risk Benefit
Guidelines | PDF Downloads